Samsung

Samsung Biologics and Pfizer in Biosimilars Pact

South Korean CDMO Samsung Biologics has entered into a long-term manufacturing partnership with major drugmaker Pfizer.

Glenfarne and Samsung Link on Chile Hydrogen Fuels

US energy and infrastructure developer Glenfarne Energy Transition has entered into a collaboration with South Korean contractor Samsung Engineering to conduct feasibility studies for multiple green hydrogen and ammonia projects in Chile.

News

GreenLight and Samsung Achieve Commercial mRNA Run

The strategic partnership of Boston-based US biotech GreenLight Biosciences and Korean CDMO Samsung Biologics has completed the first commercial-scale engineering run for its mRNA production.

News

Samsung Super Plant to Supply AstraZeneca

Korean CMO Samsung Biologics has signed on with AstraZeneca to support the UK drugmaker’s biologics therapeutics. The company will produce bulk drug substance and drug product for its customer at its new $2 billion Plant 3 facility in Incheon, South Korea, set to go on stream in 2022.

News

Powering The Next Generation

Top-Feature

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Sasol

Leading Transformation

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Dow Chemical Company

Anchored in Sustainability

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.